scholarly journals A missing cornerstone in the Norwegian Priority Commission’s weighting scheme – Sub-treatment balancedness is a necessary property for priority setting criteria

2016 ◽  
Vol 4 (2) ◽  
pp. 8-23 ◽  
Author(s):  
Mathias Barra ◽  
Kim Rand-Hendriksen

The Norwegian government recently put in place a priority commission tasked with suggesting a set of explicit criteria for priority setting in the health care sector. The commission suggested three criteria, the first two of which equate to cost-effectiveness, where, essentially, the gain is measured in terms of Quality Adjusted Life Years (QALYs). The third criteria specifies that the number of QALYs be multiplied by a factor depending on the total health loss – also measured in QALYs – without the treatment in question.In this paper, we will show that the suggested weighting scheme creates contradictory situations in which the priority of treatment programmes will change based on arbitrary bundling (where two or more treatments are combined into one) or sub-divisions (where a treatment is split up into two or more components.)We show that these types of problems can be avoided or ameliorated if the QALY weighting scheme satisfies a property which we call sub-treatment balanced – informally, that the total weighted QALY gain is preserved when treatments are bundled or sub-divided. To our best knowledge, this property has not previously been discussed in the priority setting literature.We demonstrate that sub-treatment balance can easily be achieved in general, and in particular we show how to adapt the weighting scheme suggested by the Norwegian priority commission in order to satisfy this sub-treatment balance. Finally, we argue that any weighting scheme used in health care priority setting should be sub-treatment balanced with respect to any other attribute of a treatment which policy makers would want to take into account when making their decisions.At the time of writing, the Norwegian government has yet to conclude on a final set of criteria for prioritization, and a task-group, lead by professor Jon Magnussen, is re-evaluating the severity criterion suggested by the priority commission. However, sub-treatment balance is still relevant, as it should be required of any weighing scheme, and is crucial given that (i) the criterion results in weighting QALYs, and (ii) if the selected measure of severity is affected by the administered treatment. Published: Online November 2015. In print August 2016.

2006 ◽  
Vol 22 (2) ◽  
pp. 235-241 ◽  
Author(s):  
Pirjo Räsänen ◽  
Eija Roine ◽  
Harri Sintonen ◽  
Virpi Semberg-Konttinen ◽  
Olli-Pekka Ryynänen ◽  
...  

Objectives: The objectives of this study were to identify, in a systematic literature review, published studies having used quality-adjusted life years (QALYs) based on actual measurements of patients' health-related quality of life (HRQoL) and to determine which HRQoL instruments have been used to calculate QALYs. Furthermore, the aims were to characterize studies with regard to medical specialty, intervention studied, results obtained, quality, country of origin, QALY gain observed, and interpretation of results regarding cost-effectiveness.Methods: Systematic searches of the literature were made using the MEDLINE, Embase, CINAHL, SCI, and Cochrane Library electronic databases. Initial screening of identified articles was based on abstracts read independently by two of the authors; full-text articles were again evaluated by two authors, who made the final decision on which articles should be included.Results: The search identified 3,882 articles; 624 were obtained for closer review. Of the reviewed full-text articles, seventy reported QALYs based on actual before–after measurements using a valid HRQoL instrument. The most frequently used instrument was EuroQol HRQoL instrument (EQ-5D, 47.5 percent). Other instruments used were Health Utilities Index (HUI, 8.8 percent), the Rosser–Kind Index (6.3 percent), Quality of Well-Being (QWB, 6.3 percent), Short Form-6D (SF-6D, 5.0 percent), and 15D (2.5 percent). The rest (23.8 percent) used a direct valuation method: Time Trade-Off (10.0 percent), Standard Gamble (5.0 percent), visual analogue scale (5.0 percent), or rating scale (3.8 percent). The most frequently studied medical specialties were orthopedics (15.5 percent), pulmonary diseases (12.7 percent), and cardiology (9.9 percent). Ninety percent of the studies came from four countries: United Kingdom, United States, Canada, the Netherlands. Approximately half of the papers were methodologically high quality randomized trials. Forty-nine percent of the studied interventions were viewed by the authors of the original studies as being cost-effective; only 13 percent of interventions were deemed not to be cost-effective.Conclusions: Although QALYs gained are considered an important measure of effectiveness of health care, the number of studies in which QALYs are based on actual measurements of patients' HRQoL is still fairly limited.


2007 ◽  
Vol 14 (1) ◽  
pp. 72-82 ◽  
Author(s):  
Peter Hirskyj

The current British Government's policy towards resource allocation for health care has been informed by the commissioned Wanless Report. This makes a case for the use of quality adjusted life years (QALYs) to form a rationale for resourcing health care and has implications for the staff and patients who work in and use the health service. This article offers a definition of the term ‘QALY’ and considers some of the strengths and weaknesses of this approach to resource distribution. An account is also given of an alternative formula, the DALY (disability adjusted life years), which can address some of the problems that are associated with QALYs. The values of the public, patients and nurses are identified and linked to the potential effect of a QALY formula. The implications of QALY use are applied to the health care of patients and a discussion is offered with regard to whether this method of resource allocation can be considered as just.


2009 ◽  
Vol 15 (2) ◽  
Author(s):  
Bjarne Robberstad

QALYs, DALYs and life years gained are all common outcome measures in economic evaluations of health interventions. While the latter is a pure measure of mortality, QALYs and DALYs are measures that combine mortality with morbidity in single numerical units, an exercise involving trade-offs between quantity for quality of health. Some authors have argued that mortality and morbidity are totally different dimensions, and combining them into a single numerical unit is nonsensious. Others have argued that the exercise is necessary in order to convert principles for resource allocation to criteria that can be used in a consistent manner. This paper has a two-fold objective, namely to discuss the differences between these health measures, and to explore what difference they are likely to make for health care priority setting in sub-Saharan Africa.<span style="color: #000000;"> </span><script type="text/javascript"></script>


2016 ◽  
Vol 33 (2) ◽  
pp. 161-186 ◽  
Author(s):  
Tyler M. John ◽  
Joseph Millum ◽  
David Wasserman

Abstract:One widely used method for allocating health care resources involves the use of cost-effectiveness analysis (CEA) to rank treatments in terms of quality-adjusted life-years (QALYs) gained. CEA has been criticized for discriminating against people with disabilities by valuing their lives less than those of non-disabled people. Avoiding discrimination seems to lead to the 'QALY trap': we cannot value saving lives equally and still value raising quality of life. This paper reviews existing responses to the QALY trap and argues that all are problematic. Instead, we argue that adopting a moderate form of prioritarianism avoids the QALY trap and disability discrimination.


Sign in / Sign up

Export Citation Format

Share Document